Ali Raif İlaç Strengthens Management Team: Umut Bal Appointed Deputy CEO

Ali Raif İlaç continues to strengthen its management staff in line with its over 60 years of pharmaceutical industry experience and sustainable growth targets. Umut Bal, who has 25 years of experience in the pharmaceutical industry, started his role as Deputy CEO at Ali Raif İlaç as of September 17, 2026.

In his new role, Bal will contribute to the company's managerial processes and strategic decision-making mechanisms, and will also take on responsibility in the transformation efforts carried out in line with Ali Raif İlaç's future goals.

25 Years of Experience in the Pharmaceutical Industry

A graduate of Özel Alman Lisesi, Umut Bal completed his undergraduate education in the Department of Mechanical Engineering at Boğaziçi Üniversitesi, and then completed his MBA at City University of New York – Baruch College in 2001.

Bal began his career in 2000 as a Financial Analyst at Deutsche Bank's New York office, and moved to the pharmaceutical industry in 2002. Throughout his career, he held various positions in marketing and sales at multinational pharmaceutical companies such as GlaxoSmithKline, Gilead Sciences and Roche.

Having taken part in transitions to lean and efficient organizational structures at different companies, Bal also led efforts to design new business models and organizational roles. During these processes, he took on responsibility for improving business processes and for organizational transformation efforts.

Before joining Ali Raif İlaç, Umut Bal led the Customer Engagement and Marketing function at Roche.

Ali Raif İlaç aims for Bal's industry experience and managerial experience across different functions to contribute to the company's strategic goals and transformation efforts.